24th Annual Discovery on Target 2026 官方网站

24th Annual Discovery on Target 2026

日期：2026年9月28日-10月1日

地点：美國, 馬薩諸塞州, 波士頓, Sheraton Boston

Choose your language

PRE-CONFERENCE EVENTS
会前活动：
9月28日

SYMPOSIA
专题研讨会

Induced Proximity-Based Drug Discovery
近接诱导型药物发现
Generative AI/Machine Learning-Driven Drug Design
生成式人工智慧/机器学习驱动药物设计

TRAINING SEMINARS
培训研讨会

SHORT COURSES
短期课程

In-depth, insightful instruction on focused topics offered by instructors who are subject-matter experts.
由各领域专家组成的讲师阵容，将就特定主题提供详尽且深具洞察力的指导。

SMALL MOLECULES & PEPTIDES
小分子和胜肽：
9月29日 - 10月1日

Emerging Drug
Targets
新兴药物标靶

Cancer Targets: Degrader & Chemical Small Molecule Approaches
癌症标靶：降解剂、小分子、化学方法
Autoimmune & CNS Targets: PPI Modulators
自体免疫和中枢神经系统标靶：PPI调节剂
Obesity Targets: Peptides & Beyond
肥胖症标靶：胜肽及其他

Novel Drug
Modalities
新药模式

PROTACs/Degraders, Molecular Glues and Proximity Inducers
PROTAC/降解剂、分子胶、近接诱导剂
Peptides & Small Molecule Conjugates
胜肽和小分子偶联物
Al/ML and Screening Tools for Discovering New Drug Entities
用于发现新型药物实体的AI/ML和筛选工具

Lead Generation
Strategies
先导化合物生成
策略

Biophysical Approaches
生物物理学方法
GPCR-Targeted Discovery
GPCR标靶发现
Library Innovations: DEL, FBDD, Covalent, D2B
化合物库创新：DEL、FBDD、共价键结、D2B

Innovative Discovery
Technologies
创新发现技术

Al/ML-Enabled Target Identification and Lead Discovery
AI/ML 支援的目标识别与先导化合物发现
Functional Proteomics for Direct-to-Biology Applications
用于D2B应用的功能性蛋白质体学
Phenotypic and Complex In Vitro Models and Assays
表型且复杂的体外模型与检测

BIOLOGICS & RADIOLIGANDS
生物制剂和放射性配体：
9月29日 - 10月1日

Antibodies Against
Challenging Targets
针对挑战性标靶的抗体

AI, Structural Validation and Novel Screening
人工智慧、结构验证、新型筛选
Intelligent Modalities and Precision Engineering
智慧模式和精准工程
Targeting Membrane Proteins and Restrictive Barriers
膜蛋白标靶与限制性屏障

Next-Generation
Conjugates
新一代偶联物

Next-Generation Targeting and Delivery
新一代标靶与递送
Linker Chemistry and Conjugation Methods
连接子化学和偶联技术
Emerging Modalities and Computational Approaches for Conjugates
新兴模式和偶联物的计算方法

Radioligand
Therapies
放射性配体疗法

Engineering Optimized Ligands, Linkers, and Radionuclides
配体优化、连接子和放射性核素设计
New Targets, Mechanisms, and Combinations
新标靶、机制与组合
Personalized Dosimetry and Theranostics
个人化剂量测定及诊疗一体化

24年来的尖端探索

Discovery on Target 汇聚了开拓药物发现未来的科学、技术与人才。二十多年来都在为各位介绍小分子、抗体及新兴疗法（包括肽、偶联物及放射性药物）上，塑造疗法创新的突破性进展。

在为期四天的会议中，七个同时进行的会议主题将吸引超过1,000名与会者，共同探讨目标探索、潜在客户开发、筛选技术、AI/ML及次世代生物制剂的进展。同时，透过简报、展览、海报展示及互动场次，旨在深化交流、促进合作并推动药物发现研究。同时，本次活动旨在透过简报、展览、海报展示和互动环节，促进交流互动、推动合作，并推动药物研发。

全体会议节目表（主题演讲）

Dennis Hu, PhD

Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach

PANEL MODERATOR:
Dennis Hu, PhD
CEO, Drug Hunter Inc.

Daniel A. Erlanson, PhD

Venture-Capitalist Insights on Trends in Drug Discovery

PANEL MODERATOR:
Daniel A. Erlanson, PhD
Chief Innovation Officer, Frontier Medicines Corporation

Armon Sharei, PhD

Starting Up: Translating Lab Ideas into Commercial Impact

PANEL MODERATOR:
Armon Sharei, PhD
Founder & CEO, Portal Biotechnologies

查看全体会议节目表（主题演讲）

“Of course I love to speak at your conferences- as I mentioned in my talk - I get a TON of value out of them and think it’s important to keep the discussion going about our progress at Pfizer.”

Timothy L. Foley, PhD, Senior Principal Scientist & Lab Head, DNA Encoded Library Selection & Pharmacology, Pfizer Global R&D Groton Labs

查看数据

1,100+

Attendees

220+

Presentations

115+

Research Posters

250+

Speakers

Exhibitors

Countries Represented